Lucia Tobar-Soria
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
P2X7 receptor or TNAP genetic blockade prevents the reduction of neuronal CTCF detected in tauopathy.
Journal: Neuropharmacology
Published: December 04, 2025
Neuronal alkaline phosphatase promotes the spread of Tau-induced pathology, and its blockade prevents neurodegeneration and memory loss.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: October 28, 2025
Tracking Neural Migration in Dentate Gyrus Using Thymidine Analogs.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 11, 2025
Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment.
Journal: Alzheimer's research & therapy
Published: July 24, 2024
TNAP and P2X7R: New Plasma Biomarkers for Alzheimer's Disease.
Journal: International journal of molecular sciences
Published: May 11, 2023
P2X7 receptor inhibition ameliorates ubiquitin-proteasome system dysfunction associated with Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: October 10, 2022
Studying the Role of P2X7 Receptor in Axonal Growth Using In Utero Electroporation Technique.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 01, 2022
TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy.
Journal: Neurobiology of disease
Published: July 19, 2021
P2X7 receptor blockade reduces tau induced toxicity, therapeutic implications in tauopathies.
Journal: Progress in neurobiology
Published: March 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026